Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR-IMHA Inclusive Research Excellence Prizes - Team Science

McMaster University

$25,000.00

Multimodal opioid-sparing postoperative pain protocol versus standard of care for patients undergoing knee and shoulder arthroscopy: a randomized controlled trial and knowledge translation strategy

EF 2022-23

Résumé
There is currently an opioid crisis in Canada, where Canadians use more opioids than people in any country except for the United States. Orthopaedic surgeons prescribe more opioids (also known as narcotics) than any other type of surgeon. Opioids have the potential to be highly addictive and can cause serious harm or even death if taken in excess. They are routinely prescribed after surgical operations even though there is little evidence to suggest that they are beneficial or needed. Knee and shoulder arthroscopy (or "scopes") are the most common orthopaedic surgeries in the world and are supposed to cause less pain than bigger open surgeries. Still, the majority of Canadian surgeons prescribe opioids after these arthroscopic surgeries. We completed a research study of 200 patients that underwent knee and shoulder arthroscopic surgeries and found that safer medications (i.e. anti-inflammatories and acetaminophen) along with an educational brochure work just as well to manage patient pain and maintain satisfaction with their care when compared to opioids. The results of this study can help ensure that patients around the world are receiving the most appropriate pain medications after surgery. We hope to communicate the results of the study to healthcare providers, patients, the community, researchers, and hospitals. We published the results in October 2022 in a top-tier medical journal and the results have also been distributed through social media, various press outlets, and presentations at medical conferences. We now plan to conduct a knowledge translation study that will involve targeted education of surgeons, nurses, and patients based on the results of the trial, and evaluate potentially practice-changing behaviours including changes to surgeon prescribing patterns and patient opioid consumption, pain control, and overall satisfaction.
Programme
CIHR-IMHA Inclusive Research Excellence Prizes - Team Science
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485091
Name
Ayeni Olufemi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Other : CIHR-IMHA Inclusive Research Excellence Prizes
Projecttitle
Multimodal opioid-sparing postoperative pain protocol versus standard of care for patients undergoing knee and shoulder arthroscopy: a randomized controlled trial and knowledge translation strategy
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
CIHR-IMHA Inclusive Research Excellence Prizes - Team Science
Keyworddelim
Knee Arthroscopy; Knowledge Translation; Opioid-Sparing; Randomized Controlled Trial; Shoulder Arthroscopy
Abstract
There is currently an opioid crisis in Canada, where Canadians use more opioids than people in any country except for the United States. Orthopaedic surgeons prescribe more opioids (also known as narcotics) than any other type of surgeon. Opioids have the potential to be highly addictive and can cause serious harm or even death if taken in excess. They are routinely prescribed after surgical operations even though there is little evidence to suggest that they are beneficial or needed. Knee and shoulder arthroscopy (or "scopes") are the most common orthopaedic surgeries in the world and are supposed to cause less pain than bigger open surgeries. Still, the majority of Canadian surgeons prescribe opioids after these arthroscopic surgeries. We completed a research study of 200 patients that underwent knee and shoulder arthroscopic surgeries and found that safer medications (i.e. anti-inflammatories and acetaminophen) along with an educational brochure work just as well to manage patient pain and maintain satisfaction with their care when compared to opioids. The results of this study can help ensure that patients around the world are receiving the most appropriate pain medications after surgery. We hope to communicate the results of the study to healthcare providers, patients, the community, researchers, and hospitals. We published the results in October 2022 in a top-tier medical journal and the results have also been distributed through social media, various press outlets, and presentations at medical conferences. We now plan to conduct a knowledge translation study that will involve targeted education of surgeons, nurses, and patients based on the results of the trial, and evaluate potentially practice-changing behaviours including changes to surgeon prescribing patterns and patient opioid consumption, pain control, and overall satisfaction.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ayeni, Olufemi
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~